GLP-1 Cost Per Month — Complete Pricing Guide

GLP-1 pricing is one of the most confusing drug cost landscapes in U.S. medicine because the same medication carries five or six different real-world prices simultaneously. The most searched questions are answered plainly below.

• 1
  How much is GLP-1 every month? List price: $935–$1,349/month · With commercial insurance + savings card: as low as $25/month · NovoCare/Lilly direct cash-pay: $199–$499/month · Medicare (2026 GENEROUS program): ~$245/month · TrumpRx platform: ~$350/month

  GLP-1 medications carry list prices that look alarming until you understand that almost no commercially insured patient actually pays that amount. Ozempic lists around $1,027/month, Wegovy around $1,349/month, Mounjaro around $1,069/month, and Zepbound around $1,060/month. But manufacturer savings cards reduce those costs dramatically for patients with commercial (private employer or marketplace) insurance: the Novo Nordisk savings card can bring Ozempic to $25/month and Wegovy to $0/month for qualifying patients. Eli Lilly’s savings programs work similarly for Mounjaro and Zepbound. For patients without insurance, the NovoCare direct pharmacy program offers Ozempic and Wegovy starting at $199/month for introductory doses and $349–$499/month for maintenance. Zepbound’s direct-to-patient program offers vials starting around $299/month. The new TrumpRx.gov platform is expected to offer injectable GLP-1s at approximately $350/month when it becomes fully operational. Medicare patients: the GENEROUS pilot program now covers these medications for eligible beneficiaries at approximately $245/month through Part D.
• 2
  What is the cheapest GLP-1 without insurance? Cheapest FDA-approved brand-name path: Zepbound vials via Lilly Direct ~$299/month (starter doses) · Wegovy pill via NovoCare: $149/month (starter doses) · Foundayo (orforglipron pill): ~$149/month through GoodRx · TrumpRx.gov: ~$350/month injectable · Compounded semaglutide (503A pharmacy): $200–$400/month — NOT FDA-approved

  For patients without insurance who want to pay as little as possible for an FDA-approved GLP-1, the best current options are: Zepbound vials through Eli Lilly’s direct-to-patient program starting around $299/month for starter doses (2.5 mg and 5 mg), which is a significant bargain compared to the retail pen price. The Wegovy pill (oral semaglutide) through NovoCare starts at $149/month for 1.5 mg starter doses — though this increases to $299/month for higher therapeutic doses. Eli Lilly’s new orforglipron pill (Foundayo), approved in 2026, is available through GoodRx starting at around $149/month for eligible cash-pay patients. These are all FDA-approved products with verified safety and potency — the most important distinction when comparing to compounded options. The TrumpRx platform, when fully operational, should offer injectable Ozempic, Wegovy, and Zepbound at approximately $350/month for cash-pay patients. Manufacturer patient assistance programs (PAP) can reduce costs to near-zero for patients below certain income thresholds — typically below 400% of the federal poverty level. Contact NovoCare at 1-833-NOVO-411 and Lilly at 1-800-545-6962 to check your PAP eligibility.
• 3
  How much is a 30-day supply of Ozempic? List price (retail): ~$1,027/month · With commercial insurance + savings card: as low as $25/month (up to $150 off/month) · NovoCare direct cash-pay: $199 first 2 months → $349/month maintenance · GoodRx coupon: ~$900–$985/month (modest reduction) · Medicare Part D (diabetes indication): ~$60/month average after 2026 OOP cap

  Ozempic is FDA-approved for type 2 diabetes management — not for weight loss — which is an important insurance distinction. For patients with commercial insurance where Ozempic is on-formulary for diabetes, the Novo Nordisk savings card brings the copay to $25/month (up to $150 off per fill, for up to 24 months). For Medicare Part D patients with diabetes, Ozempic is covered by approximately 94% of Part D plans and subject to the $2,000 annual out-of-pocket cap under the Inflation Reduction Act — once the cap is hit, remaining fills for the year are free. For self-pay patients, NovoCare’s cash-pay program offers Ozempic starting at $199/month for the first two months (starter doses) and $349/month for maintenance doses. GoodRx coupons provide modest savings from retail but don’t approach the NovoCare direct price. The single most important thing to know about Ozempic’s price: the savings card does NOT work with Medicare, Medicaid, or any government-funded insurance plan. Federal anti-kickback law prohibits it.
• 4
  How much is a 3-month supply of semaglutide? 3-month injectable (Ozempic/Wegovy) list price: ~$3,000–$4,047 · NovoCare cash-pay 3-month injectable: ~$1,047 (maintenance dose) · Wegovy pill 3-month: ~$447–$897 (NovoCare) · With commercial insurance + savings card: ~$75 total for 3 months · 90-day supply not available at all pharmacies — confirm with your provider

  A 3-month or 90-day supply of semaglutide multiplies the monthly cost, though some pharmacies offer slightly reduced per-unit prices on 90-day fills. At NovoCare cash-pay prices, three months of injectable Wegovy or Ozempic at maintenance dosing runs approximately $1,047. Three months of the Wegovy pill at therapeutic doses runs $897 (three fills at $299/month). With commercial insurance and the savings card, three months of Ozempic can cost as little as $75 total. The benefit of a 90-day supply beyond convenience: it typically triggers a one-time dispensing fee versus three separate fees, and patients who travel or face pharmacy access issues have more buffer. The limitation: GLP-1 medications are dose-escalating — you start at a low dose and increase over 16–20 weeks. A 90-day supply doesn’t make sense in early treatment when your dose will change monthly. It becomes more appropriate once you’re on a stable maintenance dose. Confirm with your prescribing provider and pharmacy that a 90-day supply is appropriate for your current dose and treatment stage before filling it.
• 5
  Can you get a GLP-1 prescription online — and is telehealth safe for this? YES — legitimate telehealth is legal and increasingly the most affordable access path · All GLP-1s require a prescription from a licensed provider · Legitimate platforms: GoodRx Weight Loss, Ro, Mochi Health, Calibrate, Hims/Hers (brand-name option) · Telehealth visits typically $0–$199 vs. $300–$500 for an in-person specialist · Warning: never buy GLP-1 drugs from a site that doesn’t require a real prescription

  Getting a GLP-1 prescription through telehealth is legal, increasingly common, and for many patients more affordable and convenient than seeing a specialist in person. The legitimate platforms — GoodRx Weight Loss, Ro, Mochi Health, Found, Calibrate, Hims, and Hers — all employ licensed healthcare providers who conduct real medical evaluations before prescribing. They access your medical history, review your health goals, and determine whether a GLP-1 medication is appropriate for you. An online consultation typically costs $0–$199, compared to $300–$500 or more for an in-person obesity medicine specialist. Many platforms also offer prescription management, dose adjustment, and ongoing check-ins that replace the traditional monthly clinic visit. Red flags to watch for: any website that offers GLP-1 medications without requiring a real prescription or medical consultation, claims to sell “FDA-approved” drugs at impossibly low prices, ships from outside the U.S., or doesn’t list licensed healthcare providers on staff. GLP-1 medications cannot legally be sold in the U.S. without a valid prescription, and the FDA has issued warnings about counterfeit and subpotent products circulating through illegitimate channels. Stick to platforms that are partnered with licensed U.S. pharmacies and employ providers who can be identified and verified.
• 6
  Can you get a GLP-1 without a doctor — no prescription? NO — all GLP-1 medications require a valid U.S. prescription · No legitimate pharmacy will dispense them without one · Any website claiming to sell GLP-1s without a prescription is selling counterfeit or unregulated product · Telehealth is the fastest legitimate path to a prescription without seeing a doctor in person

  Every FDA-approved GLP-1 medication — Ozempic, Wegovy, Mounjaro, Zepbound, the Wegovy pill, and the new Foundayo pill — requires a valid prescription issued by a licensed U.S. healthcare provider. This is not negotiable, not a technicality, and not something that varies by state. Any website, service, or platform claiming to sell genuine GLP-1 medications without requiring a prescription is either selling counterfeit products, illegally repackaged medications, products of unknown potency and purity, or some combination. The FDA has issued multiple warning letters about such operations. The counterfeit GLP-1 market is growing rapidly and has produced documented cases of incorrect dosing, contamination, and hospitalization. If you want a GLP-1 without the cost or inconvenience of an in-person doctor visit, telehealth is the answer — not bypassing the prescription requirement. A telehealth consultation for GLP-1 treatment can be completed in 24–72 hours on most platforms, costs $0–$199 for the visit, and results in a legitimate prescription sent directly to a pharmacy of your choice.
• 7
  Can I take GLP-1 for just 3 months — and what happens if I stop? You can stop any time — there’s no physical dependence · But: most research shows significant weight regain within 12 months of stopping · Weight regain is NOT a sign the drug failed — it’s how obesity works as a chronic condition · 3 months is usually not enough to reach goal weight · Long-term use is what produces sustained results

  Nothing physically prevents stopping a GLP-1 medication after three months — there’s no withdrawal, no addiction, and no medical danger from stopping. What does happen, reliably, is weight regain. A landmark follow-up study found that patients who stopped Wegovy after achieving significant weight loss regained approximately two-thirds of their lost weight within 12 months. The weight returns because GLP-1 medications manage obesity — they don’t cure it. When the drug leaves your system, the appetite and hormonal signals that contributed to weight gain in the first place reassert themselves. This is medically no different from stopping blood pressure medication: your blood pressure returns because the underlying condition wasn’t cured by the drug, it was managed. A three-month trial is worth doing to understand how your body responds to the medication — to gauge side effect tolerance, efficacy for your specific case, and practical compliance with daily or weekly dosing. But anyone expecting three months to produce permanent results is likely to be disappointed. For patients who can’t afford indefinite treatment, discussing maintenance strategies with a prescribing provider — including lower maintenance doses or strategic breaks — is worthwhile before assuming the medication simply doesn’t work.
• 8
  What is the cheapest way to get GLP-1 medications overall? Ranked cheapest to most expensive: 1) Commercial insurance + savings card ($25/mo) · 2) Foundayo/Wegovy pill via GoodRx ($149/mo) · 3) Zepbound vials Lilly Direct ($299/mo) · 4) NovoCare injectable ($199–$349/mo) · 5) TrumpRx ($350/mo) · 6) Medicare Part D (~$245/mo, qualifying) · 7) Telehealth + manufacturer program · 8) Compounded (NOT FDA-approved — legal concerns remain)

  The genuinely cheapest legitimate path to GLP-1 treatment depends entirely on your insurance situation. For patients with commercial insurance: the manufacturer savings card is the first and most important step — it can reduce a $1,000+ monthly bill to $25. If you have commercial insurance and aren’t using the savings card, you’re leaving hundreds of dollars on the table every month. For patients without insurance: the oral GLP-1 pills (Foundayo at ~$149/month and Wegovy pill at $149/month for starter doses through NovoCare or GoodRx) represent the most affordable FDA-approved entry points currently available. For patients on Medicare: the GENEROUS program and standard Part D coverage for diabetes-indicated GLP-1s have brought costs to the $245/month range — still significant but dramatically below the list price. For lower-income patients: manufacturer patient assistance programs (PAP) can reduce costs to near zero for qualifying patients. NovoCare and Lilly’s support lines process PAP applications that can take 2–6 weeks. Using HSA or FSA funds for GLP-1 costs reduces the effective price by your marginal tax rate — though confirm your plan’s current eligible expense list, as some plans require the medication to be prescribed for a qualifying medical condition.

The same medication can cost $25 or $1,349 per month depending on which row below describes your situation. Find your scenario and use it as your starting point.

Use the buttons below to find obesity medicine specialists, endocrinologists, pharmacies that stock GLP-1 medications, and metabolic health clinics near you. Always work with a licensed prescriber before starting or changing GLP-1 therapy.